Barclays PLC Sanara Med Tech Inc. Transaction History
Barclays PLC
- $353 Billion
- Q1 2025
A detailed history of Barclays PLC transactions in Sanara Med Tech Inc. stock. As of the latest transaction made, Barclays PLC holds 4,411 shares of SMTI stock, worth $135,991. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4,411
Previous 6,423
31.32%
Holding current value
$135,991
Previous $213,000
36.15%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding SMTI
# of Institutions
48Shares Held
913KCall Options Held
0Put Options Held
0-
Black Rock Inc. New York, NY197KShares$6.07 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA196KShares$6.06 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA88.8KShares$2.74 Million0.0% of portfolio
-
State Street Corp Boston, MA63.3KShares$1.95 Million0.0% of portfolio
-
Northern Trust Corp Chicago, IL40.8KShares$1.26 Million0.0% of portfolio
About Sanara MedTech Inc.
- Ticker SMTI
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 8,303,730
- Market Cap $256M
- Description
- Sanara MedTech Inc. develops, markets, and distributes wound and skin care products to physicians, hospitals, clinics, and post-acute care settings in the United States. It offers CellerateRX Surgical Activated Collagen powder and gel that are used in a range of surgical specialties to help promote patient healing; Biako¯s Antimicrobial Skin and...